The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty-one children and adolescents were treated with adjuvant low-dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease-free survival is 81%.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/1097-0142(19850915)56:6<1316::aid-cncr2820560616>3.0.co;2-d | DOI Listing |
Publication Analysis
Top Keywords
adjuvant chemotherapy
8
chemotherapy medulloblastoma
4
medulloblastoma adjuvant
4
chemotherapy cerebellar
4
cerebellar medulloblastoma
4
medulloblastoma controversial
4
controversial twenty-one
4
twenty-one children
4
children adolescents
4
adolescents treated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!